ADCY6


ADCY6: A Crucial Protein in Health and Disease

Description:

ADCY6 (adenylate cyclase 6) is a gene that encodes an enzyme known as adenylate cyclase, which plays a vital role in cellular signaling. This enzyme catalyzes the conversion of ATP (adenosine triphosphate) to cyclic AMP (cAMP), a second messenger molecule that regulates various cellular processes.

Associated Diseases:

Mutations in the ADCY6 gene have been linked to several diseases, including:

  • Congenital Central Hypoventilation Syndrome (CCHS): A rare condition characterized by impaired breathing at birth due to reduced respiratory drive.
  • Spasmodic Dysphonia: A disorder that causes uncontrollable spasms in the vocal cords, affecting speech.
  • Coronary Artery Disease (CAD): ADCY6 mutations have been associated with an increased risk of CAD, a leading cause of heart attacks.
  • Type 2 Diabetes Mellitus (T2DM): Decreased ADCY6 activity has been implicated in the development of insulin resistance and T2DM.
  • Insulinomas: Rare pancreatic tumors that secrete excessive insulin, leading to hypoglycemia.

Did you Know ?

  • Mutations in ADCY6 are estimated to occur in approximately 1 in 200,000 newborns worldwide.

Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.